Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome

PHASE2RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

September 10, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

April 30, 2026

Conditions
Tourette Syndrome
Interventions
DRUG

Gemlapodect

Gemlapodect is an investigational selective PDE10A inhibitor with a potential therapeutic effect for the treatment of tics associated with TS. Administered in the form of oral capsules.

DRUG

Placebo

Administered in the form of oral capsules with inert ingredients.

Trial Locations (50)

1013

COMPLETED

Noema TTS-201 Site #30, Budapest

1021

COMPLETED

Noema TTS-201 Site #11, Budapest

9000

COMPLETED

Noema TTS-201 Site #06, Ghent

10003

ACTIVE_NOT_RECRUITING

Noema TTS-201 Site #82, New York

11794

RECRUITING

Noema TTS-201 Site #03, Stony Brook

23805

RECRUITING

Noema TTS-201 Site #18, Petersburg

28211

RECRUITING

Noema TTS-201 Site #57, Charlotte

28922

RECRUITING

Noema TTS-201 Site #27, Madrid

29405

RECRUITING

Noema TTS-201 Site #73, North Charleston

30071

RECRUITING

Noema TTS-201 Site #87, Peachtree Corners

30318

RECRUITING

Noema TTS-201 Site #79, Atlanta

30625

RECRUITING

Noema TTS-201 Site #09, Hanover

32561

RECRUITING

Noema TTS-201 Site #54, Gulf Breeze

32751

RECRUITING

Noema TTS-201 Site #44, Maitland

32763

ACTIVE_NOT_RECRUITING

Noema TTS-201 Site #84, Orange City

32802

RECRUITING

Noema TTS-201 Site #61, Orlando

33011

RECRUITING

Noema TTS-201 Site #17, Oviedo

33013

RECRUITING

Noema TTS-201 Site #05, Hialeah

33175

WITHDRAWN

NOE-TTS-201 Site #62, Miami

33777

RECRUITING

Noema TTS-201 Site #71, Largo

34957

RECRUITING

Noema TTS-201 Site #97, Jensen Beach

36303

ACTIVE_NOT_RECRUITING

Noema TTS-201 Site #63, Dothan

37203

RECRUITING

Noema TTS-201 Site #98, Nashville

40097

COMPLETED

Noema TTS-201 Site #13, Katowice

40123

COMPLETED

Noema TTS-201 Site #14, Katowice

40225

RECRUITING

Noema TTS-201 Site #35, Düsseldorf

41013

RECRUITING

NOE-TTS-201 Site #28, Seville

44130

RECRUITING

Noema TTS-201 Site #58, Middleburg Heights

48105

RECRUITING

Noema TTS-201 Site #51, Ann Arbor

59000

RECRUITING

NOE-TTS-201 Site #32, Lille

60693

COMPLETED

Noema TTS-201 Site #29, Poznan

63304

RECRUITING

Noema TTS-201 Site #96, Saint Charles

68526

RECRUITING

Noema TTS-201 Site #93, Lincoln

69677

RECRUITING

Noema TTS-201 #07, Bron

75243

RECRUITING

Noema TTS-201 Site #42, Dallas

76104

RECRUITING

Noema TTS-201 Site #22, Fort Worth

78249

RECRUITING

Noema TTS-201 Site #94, San Antonio

80336

RECRUITING

NOE-TTS-201 Site #25, Munich

80542

COMPLETED

Noema TTS-201 Site #24, Gdansk

84097

RECRUITING

Noema TTS-201 Site #45, Orem

85351

RECRUITING

Noema TTS-201 Site #81, Sun City

86000

RECRUITING

Noema TTS-201 Site #08, Poitiers

90706

RECRUITING

Noema TTS-201 Site #95, Bellflower

91203

RECRUITING

Noema TTS-201 Site #75, Glendale

94596

RECRUITING

Noema TTS-201 Site #21, Walnut Creek

94903

RECRUITING

Noema TTS-201 Site #59, San Rafael

02114

RECRUITING

Noema TTS-201 Site #55, Boston

08041

RECRUITING

Noema TTS-201 Site #26, Barcelona

09006

RECRUITING

Noema TTS-201 Site #15, Burgos

08190

RECRUITING

Noema TTS-201 Site #16, Sant Cugat del Vallès

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Noema Pharma AG

INDUSTRY

NCT06315751 - Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome | Biotech Hunter | Biotech Hunter